These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31683550)

  • 1. The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development.
    Zhu W; Banadyga L; Emeterio K; Wong G; Qiu X
    Viruses; 2019 Oct; 11(11):. PubMed ID: 31683550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
    Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
    J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research progress on ebola virus glycoprotein].
    Ding GY; Wang ZY; Gao L; Jiang BF
    Bing Du Xue Bao; 2013 Mar; 29(2):233-7. PubMed ID: 23757858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus.
    Mohan GS; Li W; Ye L; Compans RW; Yang C
    PLoS Pathog; 2012; 8(12):e1003065. PubMed ID: 23271969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of Ebola virus GP and sGP in complex with therapeutic antibodies.
    Pallesen J; Murin CD; de Val N; Cottrell CA; Hastie KM; Turner HL; Fusco ML; Flyak AI; Zeitlin L; Crowe JE; Andersen KG; Saphire EO; Ward AB
    Nat Microbiol; 2016 Aug; 1(9):16128. PubMed ID: 27562261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice.
    Li W; Ye L; Carrion R; Mohan GS; Nunneley J; Staples H; Ticer A; Patterson JL; Compans RW; Yang C
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S398-403. PubMed ID: 25877553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs.
    Hoenen T; Marzi A; Scott DP; Feldmann F; Callison J; Safronetz D; Ebihara H; Feldmann H
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S242-6. PubMed ID: 25957965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway.
    Furuyama W; Shifflett K; Feldmann H; Marzi A
    PLoS Pathog; 2021 Sep; 17(9):e1009937. PubMed ID: 34529738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor.
    Volchkova VA; Dolnik O; Martinez MJ; Reynard O; Volchkov VE
    J Infect Dis; 2015 Oct; 212 Suppl 2():S226-33. PubMed ID: 26138826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 11. Ebola virus-induced eye sequelae: a murine model for evaluating glycoprotein-targeting therapeutics.
    Lee HN; Xu B; Lewkowicz AP; Engel K; Kelley-Baker L; McWilliams IL; Ireland DDC; Kielczewski JL; Li J; Fariss RN; Campos MM; Baum A; Kyratsous C; Pascal K; Chan CC; Caspi RR; Manangeeswaran M; Verthelyi D
    EBioMedicine; 2024 Jun; 104():105170. PubMed ID: 38823088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new Ebola virus nonstructural glycoprotein expressed through RNA editing.
    Mehedi M; Falzarano D; Seebach J; Hu X; Carpenter MS; Schnittler HJ; Feldmann H
    J Virol; 2011 Jun; 85(11):5406-14. PubMed ID: 21411529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The induction and characterization of monoclonal antibodies specific to GP of Ebola virus.
    Tian X; Chen D; Wang H; Xu S; Zhu L; Wu X; Wu Z
    J Med Virol; 2020 Aug; 92(8):996-1006. PubMed ID: 31663613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multiple roles of sGP in Ebola pathogenesis.
    de La Vega MA; Wong G; Kobinger GP; Qiu X
    Viral Immunol; 2015 Feb; 28(1):3-9. PubMed ID: 25354393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of rVSVΔG-ZEBOV-GP glycoproteins using automated capillary western blotting.
    Minsker K; Rustandi RR; Ha S; Loughney JW
    Vaccine; 2020 Oct; 38(45):7166-7174. PubMed ID: 32951937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis.
    Feldmann H; Volchkov VE; Volchkova VA; Klenk HD
    Arch Virol Suppl; 1999; 15():159-69. PubMed ID: 10470276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop.
    Banadyga L; Zhu W; Kailasan S; Howell KA; Franaszek K; He S; Siragam V; Cheng K; Yan F; Moffat E; Cao W; Leung A; Embury-Hyatt C; Aman MJ; Qiu X
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus.
    Audet J; Wong G; Wang H; Lu G; Gao GF; Kobinger G; Qiu X
    Sci Rep; 2014 Nov; 4():6881. PubMed ID: 25375093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection.
    Williamson LE; Flyak AI; Kose N; Bombardi R; Branchizio A; Reddy S; Davidson E; Doranz BJ; Fusco ML; Saphire EO; Halfmann PJ; Kawaoka Y; Piper AE; Glass PJ; Crowe JE
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.